Astec LifeSciences Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Astec LifeSciences han disminuido a una tasa media anual de -10.2%, mientras que en la industria Chemicals los beneficios crecieron en un 16.6% anualmente. Los ingresos han ido creciendo a una tasa media de 6.4% al año.
Información clave
-16.0%
Tasa de crecimiento de los beneficios
-16.0%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 17.7% |
| Tasa de crecimiento de los ingresos | 1.2% |
| Rentabilidad financiera | -0.3% |
| Margen neto | -0.6% |
| Última actualización de beneficios | 31 Mar 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15
Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares
Nov 17Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Astec LifeSciences. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 24 | 1,558 | -10 | 147 | 0 |
| 31 Dec 23 | 4,317 | -509 | 610 | 0 |
| 30 Sep 23 | 4,981 | -258 | 579 | 0 |
| 30 Jun 23 | 5,871 | 60 | 557 | 0 |
| 31 Mar 23 | 6,285 | 256 | 533 | 0 |
| 31 Dec 22 | 7,735 | 736 | 571 | 0 |
| 30 Sep 22 | 8,297 | 975 | 586 | 0 |
| 30 Jun 22 | 7,325 | 883 | 550 | 0 |
| 31 Mar 22 | 6,769 | 899 | 513 | 0 |
| 31 Dec 21 | 5,803 | 708 | 447 | 0 |
| 30 Sep 21 | 5,230 | 531 | 418 | 0 |
| 30 Jun 21 | 5,754 | 619 | 402 | 0 |
| 31 Mar 21 | 5,587 | 650 | 394 | 0 |
| 31 Dec 20 | 5,698 | 723 | 379 | 0 |
| 30 Sep 20 | 5,786 | 774 | 354 | 0 |
| 30 Jun 20 | 5,639 | 648 | 331 | 0 |
| 31 Mar 20 | 5,287 | 475 | 309 | 0 |
| 31 Dec 19 | 4,844 | 291 | 280 | 0 |
| 30 Sep 19 | 4,781 | 269 | 274 | 0 |
| 30 Jun 19 | 4,507 | 331 | 263 | 0 |
| 31 Mar 19 | 4,382 | 357 | 262 | 0 |
| 31 Dec 18 | 4,246 | 402 | 261 | 0 |
| 30 Sep 18 | 3,781 | 374 | 248 | 0 |
| 30 Jun 18 | 3,611 | 325 | 235 | 0 |
| 31 Mar 18 | 3,676 | 349 | 229 | 0 |
| 31 Dec 17 | 3,254 | 212 | 236 | 0 |
| 30 Sep 17 | 3,119 | 148 | 228 | 0 |
| 30 Jun 17 | 3,008 | 192 | 226 | 0 |
| 31 Mar 17 | 2,987 | 191 | 213 | 0 |
| 31 Dec 16 | 3,167 | -29 | 188 | 0 |
| 30 Sep 16 | 2,865 | -114 | 193 | 0 |
| 30 Jun 16 | 2,643 | -206 | 182 | 0 |
| 31 Mar 16 | 2,330 | 50 | 163 | 0 |
| 31 Dec 15 | 2,629 | -115 | 282 | 2 |
| 30 Sep 15 | 2,777 | 61 | 254 | 2 |
| 30 Jun 15 | 2,728 | 84 | 129 | 0 |
| 31 Mar 15 | 2,669 | 148 | 134 | 0 |
| 31 Dec 14 | 2,212 | 131 | 218 | 3 |
| 30 Sep 14 | 2,147 | 127 | 217 | 3 |
| 30 Jun 14 | 2,156 | 96 | 117 | 0 |
| 31 Mar 14 | 2,070 | 87 | 212 | 3 |
| 31 Dec 13 | 2,179 | 97 | 184 | 5 |
| 30 Sep 13 | 2,076 | 76 | 182 | 5 |
| 30 Jun 13 | 1,849 | 72 | 174 | 5 |
Ingresos de calidad: ASTEC actualmente no es rentable.
Margen de beneficios creciente: ASTEC actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ASTEC no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 10.2% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ASTEC en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: ASTEC no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (-4.9%).
Rentabilidad financiera
Alta ROE: ASTEC tiene una rentabilidad financiera negativa (-12.88%), ya que actualmente no es rentable.